Abstract P1-09-12: Comparative Analysis of the Oncotype DX Breast Recurrence Score® assay for Neoadjuvant Letrozole/Abemaciclib versus Chemotherapy in Stage II-III, Ki67≥20%, HR+/HER2- Breast Cancer: Insights from the GEICAM/CARABELA Trial | Publicación